These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29150253)

  • 1. Anti-IgE or Anti-IL5: That Is the Question.
    Israel E; Panettieri RA
    J Allergy Clin Immunol Pract; 2018; 6(3):782-784. PubMed ID: 29150253
    [No Abstract]   [Full Text] [Related]  

  • 2. Summaries for patients. Omalizumab therapy for patients with severe asthma.
    Ann Intern Med; 2011 May; 154(9):I28. PubMed ID: 21536934
    [No Abstract]   [Full Text] [Related]  

  • 3. New aspects in the treatment of asthma: targeted therapy.
    Wang ZL
    Chin Med J (Engl); 2008 Apr; 121(7):640-8. PubMed ID: 18466686
    [No Abstract]   [Full Text] [Related]  

  • 4. Treating asthma with anti-IgE or anti-IL5.
    Lötvall J; Pullerits T
    Curr Pharm Des; 1999 Oct; 5(10):757-70. PubMed ID: 10529435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-IgE and chemotherapy: a critical appraisal of treatment options for severe asthma.
    Walters EH; Walters JA; Wood-Baker R
    Expert Opin Pharmacother; 2007 Apr; 8(5):585-92. PubMed ID: 17376014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric Asthma--do we need more innovation for treatment?
    Riedler J
    Pediatr Allergy Immunol; 2014 Feb; 25(1):19-20. PubMed ID: 24588482
    [No Abstract]   [Full Text] [Related]  

  • 7. Reassessing the Th2 cytokine basis of asthma.
    O'Byrne PM; Inman MD; Adelroth E
    Trends Pharmacol Sci; 2004 May; 25(5):244-8. PubMed ID: 15120489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-IgE for asthma in inner-city children.
    Geraci C; Longo G
    N Engl J Med; 2011 Jun; 364(26):2557; author reply 2557-8. PubMed ID: 21714663
    [No Abstract]   [Full Text] [Related]  

  • 9. An update on biologic-based therapy in asthma.
    Walsh GM
    Immunotherapy; 2013 Nov; 5(11):1255-64. PubMed ID: 24188679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asthma.
    Fanta CH
    N Engl J Med; 2009 Mar; 360(10):1002-14. PubMed ID: 19264689
    [No Abstract]   [Full Text] [Related]  

  • 11. Outcomes before and after treatment escalation to Global Initiative for Asthma steps 4 and 5 in severe asthma.
    Sullivan PW; Campbell JD; Ghushchyan VH; Globe G
    Ann Allergy Asthma Immunol; 2015 Jun; 114(6):462-9. PubMed ID: 25890451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-interleukin-5 therapy and severe asthma.
    Gleich GJ
    N Engl J Med; 2009 Jun; 360(24):2577; author reply 2578. PubMed ID: 19522047
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of omalizumab in asthmatic patients with IgE levels above 700 IU/mL: a retrospective study.
    Maselli DJ; Singh H; Diaz J; Peters JI
    Ann Allergy Asthma Immunol; 2013 Jun; 110(6):457-61. PubMed ID: 23706716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma.
    Holgate ST; Chuchalin AG; Hébert J; Lötvall J; Persson GB; Chung KF; Bousquet J; Kerstjens HA; Fox H; Thirlwell J; Cioppa GD;
    Clin Exp Allergy; 2004 Apr; 34(4):632-8. PubMed ID: 15080818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic agents for severe asthma patients: clinical perspectives and implications.
    Caruso M; Morjaria J; Emma R; Amaradio MD; Polosa R
    Intern Emerg Med; 2018 Mar; 13(2):155-176. PubMed ID: 29238905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistency of response to omalizumab therapy in severe allergic (IgE-mediated) asthma.
    Bousquet J; Siergiejko Z; Swiebocka E; Humbert M; Rabe KF; Smith N; Leo J; Peckitt C; Maykut R; Peachey G
    Allergy; 2011 May; 66(5):671-8. PubMed ID: 21255035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of the Asthma Control Composite outcome measure to predict omalizumab response.
    Harris JM; Wong DA; Kapp AV
    Ann Allergy Asthma Immunol; 2011 Sep; 107(3):273-80.e1. PubMed ID: 21875548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-IgE therapy].
    Chazan R
    Pneumonol Alergol Pol; 2002; 70 Suppl 1():76-81. PubMed ID: 12518645
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pneumology. Anti-IgE antibodies in the treatment of asthma].
    Leuenberger P; Sauty A; Rochat T
    Rev Med Suisse; 2007 Jan; 3(93):56-9. PubMed ID: 17354662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three months' administration of anti-IgE to a patient with Churg-Strauss syndrome.
    Giavina-Bianchi P; Giavina-Bianchi M; Agondi R; Kalil J
    J Allergy Clin Immunol; 2007 May; 119(5):1279; author reply 1279-80. PubMed ID: 17349685
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.